Terms: = Pancreatic cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Staging
280 results:
1. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
2. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
Jehan FS; Khreiss M; Seth A; Aziz H
J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
[TBL] [Abstract] [Full Text] [Related]
3. [Survival of patients with pancreatic ductal adenocarcinoma].
Targarona J; Rivero L; Coayla G; Roman G; Rivas D; Legua S; Carrasco R
Rev Gastroenterol Peru; 2023; 43(4):300-308. PubMed ID: 38228295
[TBL] [Abstract] [Full Text] [Related]
4. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Doppenberg D; Stoop TF; van Dieren S; Katz MHG; Janssen QP; Nasar N; Prakash LR; Theijse RT; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG;
Ann Surg Oncol; 2024 Mar; 31(3):1919-1932. PubMed ID: 38170408
[TBL] [Abstract] [Full Text] [Related]
5. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract] [Full Text] [Related]
6. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper gastrointestinal cancer patients.
Jakobsen SS; Frøkjaer JB; Fisker RV; Kristensen SR; Thorlacius-Ussing O; Larsen AC
J Thromb Thrombolysis; 2024 Jan; 57(1):11-20. PubMed ID: 37792208
[TBL] [Abstract] [Full Text] [Related]
7. Long-term cancer Survival Trends by Updated Summary Stage.
Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
[TBL] [Abstract] [Full Text] [Related]
8. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma.
Zhu L; Shen S; Wang H; Zhang G; Yin X; Shi X; Gao S; Han J; Ren Y; Wang J; Jiang H; Guo S; Jin G
BMC Cancer; 2023 Aug; 23(1):790. PubMed ID: 37612635
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
[TBL] [Abstract] [Full Text] [Related]
10. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from
Gao J; Bai Y; Miao F; Huang X; Schwaiger M; Rominger A; Li B; Zhu H; Lin X; Shi K
Clin Radiol; 2023 Oct; 78(10):746-754. PubMed ID: 37487840
[TBL] [Abstract] [Full Text] [Related]
12. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
[No Abstract] [Full Text] [Related]
14. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
Honselmann KC; Elser Y; Boeckmann T; Bolm L; Winkel MT; Deichmann S; Braun R; Wellner UF; Keck T; Lapshyn H
Surgery; 2023 Sep; 174(3):674-683. PubMed ID: 37349251
[TBL] [Abstract] [Full Text] [Related]
15. pancreaticoduodenectomy in patients with an unusual course of the hepatic artery.
Skalický P; Loveček M; Tesaříková J; Gregořík M; Knápková K; Kovář R; Klos D
Rozhl Chir; 2023; 102(3):111-118. PubMed ID: 37344204
[TBL] [Abstract] [Full Text] [Related]
16. A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma.
Wang H; Wang R; Fang J
Aging (Albany NY); 2023 Jun; 15(11):4906-4925. PubMed ID: 37301543
[TBL] [Abstract] [Full Text] [Related]
17. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study.
Su YY; Chao YJ; Wang CJ; Liao TK; Su PJ; Huang CJ; Chiang NJ; Yu YT; Tsai HM; Chen LT; Shan YS
Int J Surg; 2023 Sep; 109(9):2614-2623. PubMed ID: 37300888
[TBL] [Abstract] [Full Text] [Related]
18. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
19. pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
[TBL] [Abstract] [Full Text] [Related]
20. The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.
Giuliani G; Guerra F; Messinese S; Santelli F; Salvischiani L; Esposito S; Ferraro L; Esposito A; De Pastena M; Rega D; Delrio P; La Raja C; Spinelli A; Massaron S; De Nardi P; Kauffmann EF; Boggi U; Deidda S; Restivo A; Marano A; Borghi F; Piccoli M; Depalma N; D'Ugo S; Spampinato M; Cozzani F; Del Rio P; Marcellinaro R; Carlini M; De Rosa R; Scabini S; Maiello F; Polastri R; Turri G; Pedrazzani C; Zese M; Parini D; Casaril A; Moretto G; De Leo A; Catarci M; Trapani R; Zonta S; Marsanic P; Muratore A; Di Franco G; Morelli L; Coppola A; Caputo D; Andreuccetti J; Pignata G; Mastrangelo L; Jovine E; Mazzola M; Ferrari G; Mariani L; Ceccarelli G; Giuseppe R; Bolzon S; Grasso M; Testa S; Germani P; de Manzini N; Langella S; Ferrero A; Coletta D; Bianchi PP; Bengala C; Coratti A;
Surg Oncol; 2023 Apr; 47():101907. PubMed ID: 36924550
[TBL] [Abstract] [Full Text] [Related]
[Next]
